Clinical Enroll
Free Early Access

Know if your site can enroll. Before you commit.

Clinical Enroll's AI feasibility tool analyzes your protocol against local patient population data, competing trial activity, and digital channel viability. You get a full enrollment report in 24 hours.

Up to 3 studies free24-hour deliveryPDF + web reportNo call required
Get Your Free Report

Six analyses. One document. 24 hours.

Most sites answer feasibility questionnaires from memory or from a single prior campaign. The Clinical Enroll report gives you protocol-specific data sourced from patient population estimates, ClinicalTrials.gov, and digital channel benchmarks.

Patient Enrollment Funnel

Projected path from ad response to randomization. Leads generated, protocol-screened patients, and enrolled patients modeled from your protocol's criteria and local population data.

Estimated Cost Per Randomized Patient

Budget range based on your protocol's leads-to-randomization ratio and CPL benchmarks for your indication. Know your expected cost before you commit.

Competitive Landscape

Are other trials actively recruiting for the same patients within 50 miles of your site? We check every active competing study and tell you whether your patient pool is contested or exclusive.

Digital Outreach Potential

Channel-by-channel scoring for Meta and Google Ads. We assess reach, audience targetability, and estimated CPL for your specific indication and site geography.

Protocol Risk Assessment

What works in your favor and what works against you, specific to your eligibility criteria, patient population, and site geography. Plus what it all means for your enrollment timeline.

Recommended Campaign Approach

The specific creative strategy, pre-screening questionnaire design, and channel mix Clinical Enroll would build for this study. Actionable whether you run the campaign with us or not.

A sample of what you receive.

Each report is generated for your specific NCT number, site location, and enrollment target. Below is an excerpt from an Eosinophilic Asthma Phase 3 analysis.

Executive Summary

Recruitment
Outlook

Sponsor

Your Sponsor

Phase

Phase 2/3

Enrollment Target

Your Target

US Sites

Active

Digital Outreach

8/10

Meta + Google

Difficulty

Moderate

Eligibility complexity

Enrollment Analysis

The Patient Enrollment Funnel

1 in 35

ad responses converts to an enrolled patient

1 in 3

leads qualify for screening

8%

screened go on to randomize

Competitive Landscape

Competing Trial Activity in Your Geography

Uncontested50-mile radius

100%

Uncontested patient pool

No other site is recruiting for the same eligible patients in your market.

~25%

Est. CPL reduction vs. contested markets

0

Competing studies seen by patients here

Exclusive recruitment territory

Budget Intelligence

Estimated Cost Per Randomized Patient

$6,300–$11,200

Estimated cost per randomized patient

At $180–$320 CPL, the 35:1 lead ratio implies this range per randomized patient.

Estimated time to enrollment target10–16 months
10mo16mo

Patient Population

~25M addressable

Leads That Qualify

13%

Built for site-side professionals.

Site Directors

A sponsor asks if your site can enroll 10 patients by Q3. The report tells you if it's actually achievable — and what it would cost.

Study Coordinators

You're completing a sponsor feasibility questionnaire. The report gives you enrollment funnel data and realistic timeline estimates to fill it accurately.

Principal Investigators

You're evaluating whether to take on a protocol. The competitive landscape and patient population data tell you what you're walking into before you commit.

From NCT number to full report in 24 hours.

01

Submit your NCT number

Paste your study's ClinicalTrials.gov identifier. Submit up to 3 studies at once during early access. No call required.

02

We run the analysis

Our AI cross-references your protocol's criteria against patient population data, active competing trials, and digital channel reach for your site geography.

03

You receive the full report

Within 24 hours. Web report plus PDF download. Enrollment funnel, cost estimates, competitive landscape, channel scoring, and a recommended campaign approach.

Submit up to 3 studies. Get all three free.

During early access, Clinical Enroll is generating enrollment feasibility reports at no cost for qualifying research sites. Submit your NCT numbers and receive your full reports within 24 hours.

Up to 3

Studies per submission

Within 24 hours

Delivery

Free

Cost

PDF + web report

Format

GHL Early Access Form

Replace this placeholder with the new GHL embed once created.

Early access is available to clinical research sites in the United States. Reports are generated using ClinicalTrials.gov data, U.S. Census population estimates, and Clinical Enroll's channel benchmarks.